These medications bind to GLP-1 receptors and mimic the hormones activity, offering powerful results for both weight loss and blood sugar control
If you'd like to share or republish this content for noncommercial use, please include a link back to ZipHealth for proper attribution.
Phase 2 trials showed up to 24.2% weight loss at 48 weeks, more than any other GLP-1 class medication tested so far
Nutritional priorities to support GLP 1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Titration on Compounded vs Commercial GLP-1s Compounded GLP-1 medications often follow similar titration schedules to commercial products, but there can be more flexibility
Protection against age-related metabolic decline